Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.00%)
As of: Sep 3, 2026 · 11:52 AM EDT

Endovia Health Sciences (EDVA) Change in Account Payables (2012 - 2020)

Analysis

Endovia Health Sciences (EDVA) Change in Account Payables (2012 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 141.50 Bn 133.65 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn -
3 Argenx Se 65.05 Bn 59.86 Bn 1.37 Bn -
4 Moderna 57.11 Bn 51.98 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.71 Bn 44.71 Bn - 5.03 Mn
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn -
8 Royalty Pharma 28.16 Bn 27.32 Bn - -
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn -
10 Endovia Health Sciences 801,166.21 558,464.21 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -90,000.00
Jun 30, 2020 45,000.00
Mar 31, 2020 6,000.00
Dec 31, 2019 39,000.00
Jun 30, 2019 -56,746.00
Mar 31, 2019 35,684.00
Dec 31, 2018 65,771.00
Sep 30, 2018 23,329.00
Jun 30, 2018 -88,284.00
Mar 31, 2018 104,008.00
Dec 31, 2017 -5,560.00
Sep 30, 2017 31,438.00
Jun 30, 2017 -806.00
Mar 31, 2017 -7,933.00
Dec 31, 2016 60,432.00
Sep 30, 2016 20,820.00
Jun 30, 2016 -14,810.00
Mar 31, 2016 7,416.00
Dec 31, 2015 39,098.00
Sep 30, 2015 -12,360.00